Roble Belko & Company’s CME Group CME Stock Holding History

Roble Belko & Company’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22K	Hold	100	–	–	﹤0.01%	265
2026 Q1	$30K	Hold	100	–	–	﹤0.01%	239
2025 Q4	$27K	Hold	100	–	–	﹤0.01%	247
2025 Q3	$27K	Hold	100	–	–	﹤0.01%	217
2025 Q2	$28K	Sell	100 -10	-9%	-$2.72K	﹤0.01%	213
2025 Q1	$29K	Buy	110 +10	+10%	+$2.47K	﹤0.01%	203
2024 Q4	$23K	Hold	100	–	–	﹤0.01%	207
2024 Q3	$22K	Hold	100	–	–	﹤0.01%	200
2024 Q2	$20K	Hold	100	–	–	﹤0.01%	208
2024 Q1	$22K	Hold	100	–	–	﹤0.01%	206
2023 Q4	$21K	Hold	100	–	–	﹤0.01%	199
2023 Q3	$20K	Hold	100	–	–	﹤0.01%	179
2023 Q2	$19K	Hold	100	–	–	﹤0.01%	188
2023 Q1	$19K	Hold	100	–	–	﹤0.01%	199
2022 Q4	$17K	Hold	100	–	–	﹤0.01%	220
2022 Q3	$18K	Hold	100	–	–	﹤0.01%	206
2022 Q2	$20K	Hold	100	–	–	﹤0.01%	201
2022 Q1	$24K	Buy	+100	New	+$23.5K	﹤0.01%	212

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Roble Belko & Company's CME Position: Q2 2026 in Review

Roble Belko & Company held its CME Group (CME) position steady in Q2 2026 at 100 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #265.

Roble Belko & Company first reported a position in CME in Q1 2022 and has held it in 18 quarters since. The position peaked at $30K in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Roble Belko & Company held 100 shares of CME Group worth $22K as of Q2 2026.
Roble Belko & Company left its CME Group share count unchanged in Q2 2026.
CME Group made up ﹤0.01% of Roble Belko & Company's portfolio in Q2 2026, its #265 holding.
Roble Belko & Company first reported a position in CME Group in Q1 2022 and has held it in 18 quarters since.
Roble Belko & Company's CME Group position peaked at $30K in Q1 2026.
1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.